DataMeds AI, Inc. (MEDS) earnings per share
Annual history
Fiscal years 2024 – 2025
USD / SHARE 3 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-12-31 | -$1.43 | 2026-03-20 |
| FY 2024 | 2024-12-31 | -$0.15 | 2025-03-25 |
| FY 2024 | 2023-12-31 | -$0.06 | 2025-03-25 |
Quarterly history
Fiscal years 2024 – 2026
USD / SHARE 9 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | -$0.07 | 2026-05-19 |
| Q4 2025 | 2025-12-31 | -$0.25 | 2026-03-20 |
| Q3 2025 | 2025-09-30 | -$0.46 | 2025-11-19 |
| Q2 2025 | 2025-06-30 | -$0.11 | 2025-08-19 |
| Q1 2025 | 2025-03-31 | -$0.62 | 2025-05-12 |
| Q4 2024 | 2024-12-31 | -$0.10 | 2025-03-25 |
| Q3 2025 | 2024-09-30 | -$0.04 | 2025-11-19 |
| Q2 2025 | 2024-06-30 | -$0.01 | 2025-08-19 |
| Q1 2025 | 2024-03-31 | $0.00 | 2025-05-12 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (3 split s since 2014).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
MEDS CIK 0002030763 Source: EDGAR filings · all facts